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Abstract
Background: Alzheimer’s disease and related disorders affect a growing number of people worldwide. Quality of life is generally
good in the early stages of these diseases. However, many individuals fear living through the advanced stages. Such fears are
triggering requests for medical assistance in dying (MAiD) by patients with dementia. Legislation was recently passed in Canada
and the province of Quebec allowing MAiD at the explicit request of a patient who meets a set of eligibility criteria, including
competence. Some commentators have argued that MAiD should be accessible to incompetent patients as well, provided appropriate
safeguards are in place. Governments of both Quebec and Canada are currently considering whether MAiD should be accessible
through written requests made in advance of loss of capacity.
Objective: Aimed at informing the societal debate on this sensitive issue, this study will compare stakeholders’ attitudes towards
expanding MAiD to incompetent patients with dementia, the beliefs underlying stakeholders’ attitudes on this issue, and the value
they attach to proposed safeguards. This paper describes the study protocol.
Methods: Data will be collected via a questionnaire mailed to random samples of community-dwelling seniors, relatives of
persons with dementia, physicians, and nurses, all residing in Quebec (targeted sample size of 385 per group). Participants will
be recruited through the provincial health insurance database, Alzheimer Societies, and professional associations. Attitudes
towards MAiD for incompetent patients with dementia will be elicited through clinical vignettes featuring a patient with Alzheimer’s
disease for whom MAiD is considered towards the end of the disease trajectory. Vignettes specify the source of the request (from
the patient through an advance request or from the patient’s substitute decision-maker), manifestations of suffering, and how
close the patient is to death. Arguments for or against MAiD are used to elicit the beliefs underlying respondents’ attitudes.
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Results: The survey was launched in September 2016 and is still ongoing. At the time of submission, over 850 respondents
have returned the questionnaire, mostly via mail.
Conclusions: This study will be the first in Canada to directly compare views on MAiD for incompetent patients with dementia
across key stakeholder groups. Our findings will contribute valuable data upon which to base further debate about whether MAiD
should be accessible to incompetent patients with dementia, and if so, under what conditions.
(JMIR Res Protoc 2017;6(11):e208)   doi:10.2196/resprot.8118
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Introduction
Medicine aims to relieve patient suffering and cure illness [1].
When patients can no longer be cured, palliative care aims to
improve quality of life by relieving suffering [2]. Palliative care
has expanded over the past decades, although accessibility gaps
remain, notably for patients with Alzheimer’s disease and related
disorders whose illnesses are still too often not recognized as
terminal [3,4]. Moreover, despite quality palliative care, some
patients (with and without dementia) experience
treatment-refractory symptoms that may lead to medical
assistance in dying (MAiD) requests as a last resort to alleviate
suffering [5,6]. Whether MAiD should be accessible to
incompetent patients with dementia raises complex ethical and
practical issues. We designed a study to investigate the views
of stakeholders on these issues in Quebec, Canada. In this paper,
we summarize current knowledge on these issues, state the
objectives of our study, describe its methodology, and discuss
its strengths and limitations.
Legal Landscape on MAiD Internationally in Canada,
and in Quebec
Outside of Canada, euthanasia and/or physician-assisted suicide
have now been legalized in four countries (The Netherlands,
Belgium, Luxemburg, and Colombia), four US states (Oregon,
Washington, Vermont, and California) and the District of
Columbia. In the scientific literature, euthanasia commonly
refers to, “the administration of drugs with the explicit intention
of ending the patient’s life at his or her explicit request” and
physician-assisted suicide refers to, “the prescription or supply
of drugs with the explicit intention of enabling the patient to
end his or her own life” [7]. An explicit request can be made
contemporaneously or previously (ie, in advance of incapacity).
Physician-assisted suicide is also allowed by operation of a
court decision in Montana. In Switzerland, euthanasia is illegal
but assisted suicide (whether by a physician or nonphysician)
is only prohibited when done for a “selfish motive” [8-11].
Between 0.1% and 4.6% of all deaths involve MAiD in countries
where it is legal [12,13].
In most permissive jurisdictions, MAiD is not available to
individuals with dementia. Patients are either still capable but
not near enough to the end of life, or they are close enough to
the end of life but no longer capable. However, in the
Netherlands, where being at the end of life is not a condition of
eligibility for MAiD, 109 euthanasia requests from competent
patients in the early stages of dementia were granted in 2015
[6]. Furthermore, the Dutch legislation allows a physician to
comply with a euthanasia request made by a formerly competent
patient through an advance request, as long as all of the “criteria
of due care” are met (notably including unbearable suffering).
To date, four cases have been reported regarding Dutch patients
who requested euthanasia while competent via a written request,
and whose requests were granted after they had become
incompetent [6,14]. Similarly, the law in Belgium does not
require patients to be at the end of life or terminally ill, and does
permit some access to MAiD through written requests made in
advance of loss of capacity. However, in these cases the patient
must be unconscious. In Luxembourg, a patient must be in a
terminal condition, and access to MAiD is permitted through
an advance request (provided the patient is unconscious). These
requirements mean that many patients with dementia will not
qualify for MAiD, but some will.
Until recently, MAiD was prohibited in Canada under several
provisions of the Criminal Code. There have been court
challenges to these provisions over the last 25 years, the most
notable being Rodriguez v. British Columbia (Attorney General)
in 1993 [15] and, more recently, Carter v. Canada (Attorney
General) in 2015 [16]. In the first case, the Supreme Court of
Canada dismissed the appeal of Sue Rodriguez, a woman living
with amyotrophic lateral sclerosis who had challenged the
validity of the Criminal Code prohibitions on MAiD [15]. This
decision was overturned on February 6, 2015 by a unanimous
decision of the Supreme Court in Carter v. Canada [16] . The
judges ruled that the prohibitions violate section 7 of the
Canadian Charter of Rights and Freedoms.
The Court’s ruling catalyzed the Government of Canada to
engage in consultation and draft legislation specifying the
eligibility criteria and procedural safeguards for access to MAiD.
Bill C-14 came into force on June 17, 2016 [17], enacting
exemptions from criminal liability for physicians and nurse
practitioners who provide MAiD, and for others who assist
them. Eligibility is restricted to a competent adult who makes
a voluntary and well-considered request for MAiD and has a,
“grievous and irremediable medical condition” [17]. Canada
Bill C-14 defines medical assistance in dying as:
The administering by a medical practitioner or nurse
practitioner of a substance to a person, at their
request, that causes their death, or the prescribing
or providing by a medical practitioner or nurse
practitioner of a substance to a person, at their
request, so that they may self-administer the substance
and in doing so cause their own death [17]
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MAiD thus encompasses both euthanasia and physician-assisted
suicide, as defined above. A person has a grievous and
irremediable medical condition only if all of the following
criteria are met:
(a) they have a serious and incurable illness, disease,
or disability; (b) they are in an advanced state of
irreversible decline in capability; (c) that illness,
disease, or disability or that state of decline causes
them enduring physical or psychological suffering
that is intolerable to them and that cannot be relieved
under conditions that they consider acceptable; and
(d) their natural death has become reasonably
foreseeable, taking into account all of their medical
circumstances, without a prognosis necessarily having
been made as to the specific length of time that they
have remaining [17]
Contrary to recommendations made by a Provincial-Territorial
Expert Advisory Group on Physician-Assisted Dying [18] and
a Special Joint Committee of the House and Senate on
Physician-Assisted Dying [19], the federal legislation does not
allow a person to access MAiD through a request made in
advance of loss of capacity. However, the legislation mandated
an independent review and reporting back to Parliament on
several issues, including advance requests. The government has
commissioned the Council of Canadian Academies to
independently manage the review and report to Parliament by
December 2018.
On June 10, 2014, eight months before the Supreme Court’s
ruling in Carter v. Canada, the Quebec National Assembly
adopted An Act respecting end-of-life care (Bill 52) which
codifies recommendations made by the Quebec College of
Physicians [20] and the province’s Select Committee on Dying
with Dignity [21]. Briefly, Bill 52 first affirms the right of
everyone to end-of-life care that is appropriate to their needs.
The bill also regulates continuous palliative sedation, establishes
an advance medical directives regime, and permits MAiD under
strictly defined circumstances [22]. In Quebec Bill 52, MAiD
is defined as:
Care consisting in the administration by a physician
of medications or substances to an end-of-life patient,
at the patient’s request, in order to relieve their
suffering by hastening death [22]
This definition corresponds to euthanasia, as defined above.
Nurse practitioners are not authorized to administer aid in dying
under the Quebec legislation. The legislation became effective
on December 10, 2015. Eligibility for MAiD is restricted to
competent adults from Quebec who are at the end of their lives,
have made persistent explicit requests for MAiD, and:
Suffer from a serious and incurable illness, are in an
advanced state of irreversible decline in capacity,
and experience constant and unbearable physical or
psychological suffering which cannot be relieved in
a matter the patient deems tolerable (article 26) [22].
For greater clarity, article 51 specifies that MAiD may not be
requested by means of an advance medical directive.
Quebec Bill 52 has drawn both opposition and support, with
some supporters recommending that access to MAiD be
extended to incompetent patients, provided appropriate
safeguards are in place [23]. Proposed safeguards for MAiD,
should it be accessible to incompetent individuals, have
included: an explicit request made in an advance directive by
the patient while competent; consent from the patient’s legal
representative; and prior authorization of a local or provincial
body, where relatives and health professionals could be heard
[24]. Ultimately, Quebec decided not to give incompetent
patients access to MAiD through Bill 52, noting a lack of
societal consensus on this issue [25]. However, recently the
Minister of Health and Social Services announced that an expert
group will be tasked with studying whether access to MAiD
should be permitted through requests made in advance of loss
of capacity. This initiative has obvious implications for patients
with dementia.
In both Canada and the province of Quebec, eligibility criteria
for MAiD currently exclude patients who have become
incompetent due to Alzheimer’s disease or other forms of
dementia. These are serious incurable conditions that
progressively and irreversibly erode patients’ abilities to perform
basic activities of daily living. Additionally, many affected
individuals develop serious clinical complications (eg, eating
problems, pneumonia) and distressing symptoms (eg, pain,
dyspnea) that are difficult to manage [26-29]. However, by the
time a patient satisfies these criteria, he or she is unlikely to be
competent. Strong opinions have been voiced in support of, and
in opposition to, the exclusion of patients with advanced
Alzheimer’s disease and other forms of dementia. The issue of
respecting MAiD requests that are to be carried out after the
patient has lost capacity is a complex health care issue that
brings diverse societal values and beliefs into relief and conflict;
these are briefly reviewed below.
Arguments For and Against MAiD, in General and
for Incompetent Patients With Dementia
Arguments in favor of MAiD generally include individual
autonomy and freedom of choice, the inability to relieve
suffering in some cases, the absence of a moral distinction
between withholding/withdrawing potentially life-sustaining
treatment and MAiD, and the claim that permitting MAiD allows
the establishment of stronger safeguards and oversight for the
entire spectrum of end-of-life medical care through
carefully-designed regimes. Arguments against MAiD include:
the sanctity of life; the need to protect socially vulnerable
populations from abuse and social discrimination; concerns
about the slippery slope which (depending on the interpretation)
could lead to more abuse, or to the legislation being extended
to incompetent patients; the risk of impeding the development
of palliative care; and ethical tensions faced by physicians who
object to MAiD on moral grounds, but could feel or be obliged
to carry out the request [11,30-33].
Other arguments are raised against MAiD when referring
specifically to patients rendered incompetent by advanced
dementia: patients’ potential to adapt to their disease, which
may change previously expressed wishes (the so-called
“disability paradox”); the impossibility of health care providers
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and families engaging in meaningful conversations with the
patient to confirm the wish to die; and practical difficulties in
assessing suffering, balancing current preferences against earlier
wishes laid down in a now-forgotten request, and choosing the
right moment to carry out the request. Complying with an
advance request for MAiD also raises the philosophical question
of whether a request made by a previously competent person
should have any authority over the life of a person who now
has severe dementia [34-44].
Attitudes of Stakeholders Towards MAiD
Major groups of stakeholders likely to be impacted by extending
MAiD to incompetent patients include older adults, relatives of
patients with dementia, physicians, and nurses. Systematic
reviews of quantitative studies from several countries, including
Canada, show increasing support from these groups of
stakeholders for MAiD in cases of competent terminally-ill
patients experiencing severe pain who make an explicit request
[10,11,45-47]. Far fewer studies have investigated opinions of
stakeholders on MAiD for patients with dementia [48-58]. None
of these studies were conducted in Canada and only two have
focused exclusively on this issue [53,56]. As shown in Table 1,
support was found to be higher in the general population and
lower among physicians, with nurses’ opinions falling in
between. Support for advance requests for MAiD is also stronger
among the general public than among health care practitioners,
who raise numerous issues regarding their use [37,39].
In conclusion, growing knowledge of possible clinical
complications of advanced dementia, and current access to
MAiD for competent adults, will likely trigger advance requests
for MAiD from Canadians diagnosed with dementia [11,59,60].
To date, no study has investigated the attitudes and beliefs of
Canadians on this complex and sensitive issue. Similarly, no
study has examined whether Canadians support other end-of-life
medical practices in advanced dementia, such as the withholding
of antibiotics for a life-threatening pneumonia or continuous
deep sedation for agitation refractory to treatment. This study
will shed light on these specific issues, providing much-needed
evidence to support future health care policy development on
end-of-life care for Canadians with advanced dementia.














CountryFirst author (year of publication)
General Public
14168862361% over 75 yearsUnited States (Durham, NC)Koenig (1996) [49]
4591146unspecified18 or olderThe NetherlandsVan Holsteyn (1998) [50]
48587594218 to 70FinlandRyynänen (2002) [51]
621388783920 to 93The NetherlandsRietjens (2005) [52]
57 to 59725714643 (17)United Kingdom (London)Williams (2007) [53]
60 to 65625525020 to 84SwedenLindblad (2010) [54]
771960785453 (15)The NetherlandsKouwenhoven (2013) [55]
Relatives of patients with dementia
89136723857The NetherlandsRurup (2006) [56]
Physicians
8506624824 to 87FinlandRyynänen (2002) [51]
6391817663% aged 40 to 55The NetherlandsRietjens (2005) [52]
16107965141The NetherlandsRurup (2006) [56]
13 to 15667566932 to 79SwedenLindblad (2010) [54]
33793416551 (8)The NetherlandsKouwenhoven (2013) [55]
Nurses
2358273620 to 63FinlandRyynänen (2002) [51]
57148941734The NetherlandsRurup (2006) [56]
52 to 5641570.51244 (9)Belgium (Flanders)Gielen (2009) [57]
57332162.51242% aged 36 to 45Belgium (Flanders)Inghelbrecht (2009) [58]
581243unspecified1044 (11)The NetherlandsKouwenhoven (2013) [55]
aRange reported when several items were used to measure acceptability
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Research Objectives and Hypotheses
Restricted to Quebec with plans for extension to other Canadian
provinces, this study will elicit and compare the attitudes of
four groups of stakeholders (seniors, relatives of persons with
dementia, physicians, and nurses) towards MAiD for
incompetent patients with dementia, the beliefs underpinning
stakeholders’ positions on this matter, and their opinions as to
whether proposed safeguards can adequately protect incompetent
patients. Based on findings in other countries [11,31], we expect
that: (1) support for MAiD for incompetent patients with
dementia will be higher among seniors and relatives than among
health care practitioners; (2) support among health care
practitioners will increase with additional safeguards, without
reaching the level of support found in the two other groups; (3)
religiosity, slippery slope, autonomy, and dying-with-dignity
arguments will affect respondents’ permissiveness toward MAiD
for incompetent patients with dementia; and (4) the relative
weight of these arguments in shaping opinions will vary across
the four groups of stakeholders.
Methods
Study Design, Target Groups, and Sampling
An anonymous province-wide postal survey using clinical
vignettes will be conducted on random samples of
French-speaking Quebec residents belonging to one of four
groups of stakeholders: (1) community-dwelling seniors aged
65 years or older, (2) relatives of persons with dementia, and
(3) physicians and (4) nurses likely to be involved in end-of-life
decision making. In Quebec, 94% of the population speaks
French [61].
The random sample of community-dwelling seniors will come
from the Quebec health insurance database. Relatives of patients
with dementia will be reached through regional Alzheimer
Societies. To protect their members’ right to privacy,
participating Societies will randomly select a predetermined
number of potential participants (proportional to the size of their
memberships) and distribute the survey package directly to them
per our instructions. Assistance in managing the survey will be
provided by our research staff to any Society that expresses the
need. Practicing physicians and nurses will be recruited through
their respective professional bodies, excluding those in full-time
administrative, teaching, or research positions due to their
limited direct contact with patients. Specialties for physicians
will be restricted to family medicine, geriatrics, internal
medicine, neurology, psychiatry, and intensive care; for nurses,
specialties will be restricted to geriatrics/gerontology and
end-of-life care.
Postal Survey
The survey and questionnaires were designed using strategies
shown to maximize response rates and data quality [62]. As
depicted in Figure 1, randomly sampled individuals receive a
personalized cover letter and accompanying materials in week
1, and a thank-you/reminder postcard in week 3. Nonrespondents
are mailed a second survey package in week 12. The personal
letter states the aim of the survey, explains how recipients were
chosen, mentions that completing the questionnaire requires 20
minutes on average (based on pretesting), and addresses issues
of privacy and anonymity. The letter also provides the Internet
link (website address) to the online version of the questionnaire
as well as the recipient’s single-use personal identifier. A
self-addressed and stamped return envelope is enclosed in the
survey package for those who prefer to complete the printed
questionnaire.
Figure 1. Outline of the postal survey.
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A letter of endorsement from the Federation of Quebec
Alzheimer Societies is also included, with a postcard bearing
the respondent’s name, to be returned separately from the
questionnaire. Returned postcards make it possible to identify
sampled individuals who have returned the questionnaire–either
by mail or electronically–while preserving the anonymity of
their answers. The postcard also serves the purpose of
identifying sampled individuals who are no longer eligible (eg,
seniors who are now institutionalized or too cognitively impaired
to participate). The names of those who return the postcard are
immediately removed from the mailing list to prevent further
reminders. At the close of the postal survey, nonrespondents
receive a 3-item questionnaire asking: (1) for their reasons for
not participating (eg, felt questions were biased, lack of time,
or doubt that anonymity can truly be preserved); (2) how
comfortable they are with the current Quebec legislation that
gives competent patients access to MAiD if certain conditions
are met; and (3) whether they favor or oppose allowing
physicians to administer MAiD to incompetent patients, with
proper safeguards in place. The latter two questions will be used
to assess nonresponse bias.
Questionnaires
After stating the eligibility criteria for MAiD as defined in
Quebec’s Act respecting end-of-life care, the 3-part
questionnaire presents a series of multiple-choice questions,
with space for the respondent’s comments. Part 1 elicits attitudes
towards MAiD and other end-of-life practices. Two sets of
clinical vignettes are used for that purpose. The first vignette
features a cancer patient who is eligible for MAiD. Using a
5-point Likert-type scale, respondents are asked to what extent
they find it acceptable for a physician to sedate the patient
continuously until death to relieve suffering, or to comply with
the patient’s request for MAiD. The second set, containing 7
interrelated vignettes, features a woman moving along the
dementia trajectory, from the early stage when she is diagnosed
with Alzheimer’s disease to her final days of life. End-of-life
practices (besides MAiD) for which support or opposition is
investigated include withholding antibiotics for a life-threatening
infection and continuous deep sedation for refractory agitation.
Vignettes specify the source of the request for MAiD (an
advance request made in writing by the patient while she was
still competent, or her family), whether the patient appears to
be suffering (eg, showing signs of distress, crying regularly),
and whether death seems imminent. Vignettes are kept as
nontechnical as possible to be easily understood, regardless of
the respondent’s medical knowledge. A sensitive and neutral
tone is used throughout the questionnaire to prevent response
bias. Part 1 ends with a list of statements designed to capture
respondents’ reasons for supporting or opposing MAiD,
generally and for incompetent patients in particular. Reasons
include, for example: religious and moral objections, respect
for patient autonomy, practical difficulties in ascertaining
whether an incompetent patient is suffering unbearably, and
concerns about the slippery slope.
Part 2 explores related issues, such as whether respondents have
filled out an advance directive for themselves, personally know
someone with dementia, or have ever accompanied a dying
relative or friend. Respondents are also asked the likelihood
that they would request MAiD in advance of loss of capacity,
should they be diagnosed with Alzheimer’s disease, or ask a
physician to comply with such a request drafted by a loved one
under similar circumstances.
Part 3 collects sociodemographic data from all respondents (eg,
age, gender, ethnicity, degree of religiosity) and contains
additional group-specific questions. For seniors, these questions
include educational attainment and self-rated health. Relatives
are asked how long ago the person with dementia was diagnosed
and their current level of cognitive functioning. Questions for
physicians and nurses explore their experience in caring for
dying and dementia patients, training in palliative care, and
exposure to MAiD requests from patients or patients’ relatives.
Physicians are also asked whether they would be willing to
provide such assistance, were it legal. Few physicians currently
administer MAiD in Quebec, and to preserve their anonymity,
surveyed physicians are not asked whether they have in fact
provided such assistance in the past.
Questionnaires were developed in English with input from
renowned English-speaking content experts from countries
where assisted dying is legal or not criminalized. The
questionnaires were then translated into French and pretested
through cognitive interviews performed by a research assistant
with representatives of the four groups of stakeholders (n=20).
Interviews were aimed at assessing the length of the
questionnaires, clarity of the questions, uniformity in
comprehension, and respondent comfort with the content [63].
Following these interviews, minor modifications were made to
some questions, which aimed at emphasizing differences
between vignettes (eg, advanced vs. terminal stage of
Alzheimer’s disease, presence vs. absence of a written request).
Questionnaires were then converted to a Web format. The Web
questionnaires were developed using the latest version of
LimeSurvey [64], a free open-source online survey application
that allows assigning a single-use password to each sampled
individual. The server hosting the LimeSurvey software uses
proven encryption methods (Transport Layer Security) to
transmit survey answers to a secure server and export collected
data into a statistical package for analysis. Before launching the
survey, the Web version was tested in-house and with several
remote participants on different operating systems, browsers,
and platforms, and for different types and speeds of Internet
access. Systematic troubleshooting was performed to uncover
unforeseen technical problems.
Data Analyses
The data will be analyzed in four consecutive steps. First, we
will compare nonrespondents, respondents to the one-page
questionnaire only, and late versus early respondents to the full
questionnaire, to detect response bias and establish sample
weights where needed. Response rates will be reported as
recommended by the American Association for Public Opinion
Research. In Step 2, we will study patterns of item nonresponse
and determine whether imputing missing data would be
appropriate [65]. Next, we will summarize participant answers
to the questionnaire, and compare distributions of answers within
respondents, as well as within and between the four groups of
stakeholders. Within-respondent comparisons will require
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multilevel analyses, since answers to different questionnaire
items will be correlated [66]. For instance, the proportions of
respondents who support MAiD at the advanced versus terminal
stages are not independent and hence cannot be compared using
the usual Chi-square test. Estimations of model parameters will
be based on maximum likelihood with adaptive quadrature,
which outperforms other methods in terms of bias and efficiency
of the estimates when the number of study participants is large,
as is typical of survey research [67]. Respondent characteristics
will subsequently be added to the models in a stepwise fashion
to identify additional correlates of response patterns in addition
to group membership. Residual analyses will be conducted to
assess the tenability of the assumptions underlying the statistical
models, and to identify influential observations and outliers.
Multilevel modelling will be conducted with SAS Proc
NLMIXED [68], which offers a wide choice of integral
approximations and optimization techniques.
Sample Size
The data from our four samples will first be summarized with
proportions and associated confidence intervals. In the
worst-case scenario of equal proportions for and against a given
end-of-life practice, two-sided 95% confidence intervals for
proportions require 385 respondents per sample when the
semiinterval width is set at 5% (nQuery Advisor, version 7.0).
The sample size required for reliably fitting multilevel models
depends on several factors, including sample size at each level
of the analysis, number and type of predictors included in the
model, intraclass correlation, and model complexity. Recent
Monte Carlo simulation studies on multilevel models for binary
and continuous outcomes suggest that 100 to 200 level-2 units
(ie, survey respondents) with 5 to 10 level-1 units (ie,
questionnaire items) ensure model convergence and provide
adequate power for testing fixed and random effects [69]. To
determine the number of questionnaires to mail out to achieve
the target of 385 respondents per group, we applied response
rates derived by averaging those reported in Table 1 with our
own [70,71]. The resulting numbers are: 621 seniors, 527
relatives of persons with dementia, 653 physicians, and 514
nurses, for a total of 2315 potential participants.
Ethical Considerations
This study will investigate views on sensitive issues. While
there are no physical risks to participants, psychological risks
must be acknowledged. Questionnaires may trigger emotional
distress in some participants or revive painful memories of the
death and suffering of a loved one. In an effort to minimize
these risks, the cover letter that accompanies the questionnaire
includes contact details for a support resource, if needed.
Participation in the survey is voluntary and answers are
anonymous. Signed consent is not required; in anonymous
surveys, implicit consent is inferred from respondents who
return the questionnaire [72]. All information needed for
informed consent is provided in the cover letters, including a
toll-free telephone number and email address for those who
have questions or concerns about the survey. Personal
information on sampled individuals is coded, and access to
password-protected lists of codes is restricted to the research
team. Sampling lists will be destroyed five years after the end
of the study. The Research Ethics Board of the University
Institute of Geriatrics of Sherbrooke granted ethical approval
of the survey design and questionnaires (file # 2016-623).
Results
The survey was launched in September 2016 among relatives
of patients with dementia, physicians, and nurses, and is still
ongoing. The survey will be launched among older adults as
soon as we receive a random list of names extracted from the
Quebec health insurance database.
Discussion
To the best of our knowledge, this study will be the first to
uncover Quebec stakeholders’ attitudes towards MAiD for
incompetent patients with dementia, which is a vulnerable and
rapidly expanding population of patients. Dementia affects more
than 37 million people worldwide, with a projected increase to
over 115 million by 2050 [73]. The Alzheimer Society of
Canada has estimated that 564,000 Canadians were living with
dementia in 2016, and this number is expected to rise to 937,000
by 2031, representing an increase of 66% [74]. Life expectancy
after a dementia diagnosis is believed to lie between 3 and 12
years [75]. Because no cure is foreseen in the near future, many
people will die with or from dementia. Over the last decade,
deaths attributed to Alzheimer’s disease rose by 39% in the
United States [76]. Although quality of life can be good in the
early stages, dementia still ranks among the most feared clinical
conditions in modern societies [77]. Indeed, some perceive this
syndrome as a “fate worse than death” and dread the prospect
of living through the advanced stages of dementia [78,79].
People are apprehensive about the progressive loss of decisional
capacity and control, prolonged dependence upon others for
their most basic needs, inability to report physical and
psychological suffering, and lengthy periods of
institutionalization before death. As the prevalence of dementia
continues to rise, a growing number of individuals who do not
want to experience the full course of dementia might request
MAiD.
Do stakeholders believe that MAiD should be made available
to patients who have reached an advanced stage of dementia?
Under what circumstances? Are other end-of-life practices
viewed as more appropriate? Can proposed safeguards on MAiD
adequately protect vulnerable individuals from abuse and
coercion? Do views on these issues vary markedly within and
between groups of stakeholders? By using a proven research
methodology and identical questions across stakeholder groups,
this study will provide answers to these questions, which have
yet to be explored in Canada, and have only been partially
investigated in other countries.
Strengths and Limitations
The current study has strengths and limitations. Strengths
include: the timeliness of the survey, which will inform ongoing
legislative activities; random selection of potential respondents
from four highly relevant groups of stakeholders; the anonymity
of answers, which decreases bias due to social desirability; the
care taken in designing and testing the questionnaires with input
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from international content experts; and our decision to
administer a common set of questions to all four groups of
stakeholders, enabling direct comparison of their views on
MAiD for incompetent patients with dementia. The presence
of investigators on the research team who support, and others
who oppose, extending MAiD to these patients is another
strength, as it minimizes the risk of biased questions and
increases uptake of research findings [80].
Although not without limitations, surveys contribute invaluable
data to inform ethical debates, public policy development, and
future research on sensitive issues such as whether MAiD should
be extended to incompetent patients with dementia [81]. Postal
surveys offer many advantages over other data collection
methods. First, such surveys are relatively inexpensive for
surveying large and geographically dispersed populations,
provide greater flexibility for the respondents, maintain
anonymity, and yield higher response rates than telephone
surveys [62]. In our survey, sampled individuals have the option
to complete a paper or online version of the questionnaire, which
is a strategy shown to yield even higher response rates [82,83].
Second, earlier studies conducted abroad provide a solid basis
for the design of high-quality clinical vignettes featuring
incompetent patients, MAiD requests, and end-of-life practices
[49-58]. Additionally, the practical problems and moral
dilemmas created by advanced MAiD requests, and the
arguments for and against MAiD for incompetent patients with
dementia, have been thoroughly reviewed [34-44]. These
reviews have provided ample materials from which to formulate
questionnaire items for exploring beliefs underlying attitudes.
Low response rates threaten the external validity of findings
from attitude surveys. To counter this problem, both the survey
and the questionnaires were designed using strategies that
comprehensive reviews have shown to be effective [84,85].
Response rate is an imperfect indicator of survey quality,
however. Empirical assessments over the past decade have
concluded that response rates may not be as strongly associated
with survey quality as was generally believed [86]. The degree
to which respondents differ from the target population is the
central issue. Well-recognized approaches to assess nonresponse
bias and minimize its effect are part of our analytical plan and
include: inviting initial nonrespondents to complete a shorter
questionnaire with only key measures of interest, comparing
respondents with nonrespondents using information available
in the sampling frame, comparing early versus late respondents
on personal characteristics and answers to survey questions,
and weighting analyses of the variables of primary interest.
One limitation is the restriction of the survey to the province of
Quebec. We plan to extend the survey to the rest of Canada in
the near future, using the same questionnaires to enable
provincial/territorial comparisons. Short case descriptions with
a limited number of possible answers fall short of capturing the
complexity of end-of-life decision making [52]. Our upcoming
pan-Canadian survey will include a qualitative component aimed
at gaining deeper insight into respondents’ thought processes
and the reasons behind their support for, or opposition to, MAiD
for incompetent patients with dementia [43]. Opinions are
elicited using specific vignettes. Whether opinions extend to
other clinical contexts involving MAiD requests from
incompetent patients with dementia will remain unknown. We
chose not to elicit attitudes towards extending MAiD to patients
at earlier stages of dementia who are still competent. Including
cases of early and late stage dementia in the same questionnaire
would increase its length and possibly lower response rates. We
also chose not to recruit in long-term care facilities, where most
residents would be too cognitively impaired to provide reliable
and valid answers to the survey questionnaire. We do not
purposefully target seniors with dementia, even though those
at an early stage of the disease would likely have the cognitive
abilities to participate in the survey. We felt that a
self-administered questionnaire was not ethically appropriate
for this subpopulation, given the sensitive nature of the subject
under investigation [81]. However, as the views and concerns
of this population regarding end-of-life practices in advanced
dementia are highly relevant yet currently unknown, we are
simultaneously conducting a qualitative study in this population.
The data from persons with early dementia will be collected
during face-to-face interviews, allowing the interviewer to
respond promptly should questions trigger negative emotions
in some participants. Combining findings from our survey with
those from the in-depth interviews will allow more nuanced
recommendations as to whether MAiD should be expanded to
incompetent patients with dementia.
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